Eli Lilly gets CDSCO Committee nod for marketing authorization for Insulin Lispro MD Bureau1 Jan 2021 6:17 PM ISTNew Delhi: In a major rejoice to Eli Lilly and Company (India) Pvt. Ltd., the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Pfizer, SII, Bharat Biotech seek emergency use authorization for COVID vaccines: CDSCO panel to reconvene on Jan 1 Medical Dialogues Bureau31 Dec 2020 2:44 PM ISTNew Delhi: An expert panel in the Central Drugs Standard Control Organisation (CDSCO) that met on Wednesday to consider emergency use authorization...
CDSCO panel asks Hetero to resubmit Bioequivalence protocol for Trelagliptin Succinate tablet MD Bureau30 Dec 2020 7:12 PM ISTNew Delhi: Noting that the protocol was not scientifically designed and the safety of the study subjects was not taken care of, the Subject Expert...
CDSCO mandates license for import, manufacture of nebulizers, BP monitoring devices, digital thermometers, glucometer Ruchika Sharma29 Dec 2020 6:18 PM ISTNew Delhi: Through a recent notification the Central Drugs Standard Control Organization (CDSCO) has made it mandatory for importers and manufacturers...
CDSCO Declares 14 Drug Samples Including BP, dyslipidemia Drug As Not Of Standard Quality Ruchika Sharma27 Dec 2020 11:30 AM ISTNew Delhi: The apex drug regulatory body, Central Drugs Standard Organization (CDSCO) has flagged 14 drug samples as "Not of Standard Quality" after...
CDSCO panel rejects Emcure Voglibose, Vildagliptin FDC citing dosage schedule incompatibility between ingredients Farhat Nasim25 Dec 2020 1:18 PM ISTNew Delhi: Citing dosage schedule incompatibility between the ingredients, the Subject Expert Committee (SEC) functional under the Central Drugs...
COVID vaccine ZyCoV-D found safe in clinical trials: Zydus Cadila MD Bureau25 Dec 2020 11:13 AM ISTAhmedabad: Zydus Cadila announced on Thursday that its plasmid DNA vaccine to prevent COVID-19 - ZyCoV-D - was found to be safe, well tolerated and...
India likely to get COVID-19 vaccine approved for emergency use before December ends: Report MD Bureau24 Dec 2020 1:00 PM ISTThe sources said that the Pune-based SII's vaccine candidate has an edge over Pfizer's because of its low cost, effective logistics and easy storage.
Bharat Biotech re-applies with DCGI for emergency approval of Covaxin MD Bureau24 Dec 2020 10:30 AM ISTNew Delhi: Hyderabad-based Bharat Biotech, which is developing the country's indigenous coronavirus vaccine in collaboration with the Indian Council...
AstraZeneca COVID-19 vaccine likely to get emergency nod by next week in India: Report Ruchika Sharma23 Dec 2020 3:11 PM ISTThe Indian regulator is only considering the two full-dose regimen of the shot despite it showing a lower success rate, the sources said.
Semaglutide to be sold only on prescription of Endocrinologist, PG Medicine in India: CDSCO Committee Farhat Nasim22 Dec 2020 4:58 PM ISTNew Delhi: In a major development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) has...
India needs Rs 80,000 crore for COVID-19 vaccine distribution in 2021: Serum Institute of India MD Bureau20 Dec 2020 10:15 AM ISTDr. Satish D. Ravetkar added that India would further have to ensure adequate power supply that could help maintain the temperature required to keep...
